TNFRSF17 and Miyoshi myopathy: In contrast, the overall Ab levels in the WM cohorts on-therapy (Figure 2B) or off-therapy (Figure 2C), and anti-BCMA-treated MM cohort (Figure 2E) did not significantly increase, despite few individuals showed anamnestic responses.